Skip to main content
Clinical Trials/NCT01072487
NCT01072487CompletedPhase 3

Capnography as an Adjunct to Standard Monitoring During Midazolam and Propofol Sedation for Colonoscopy

Technical University of Munich6 sites in 1 country760 target enrollmentStarted: February 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
760
Locations
6
Primary Endpoint
Hypoxemia

Study Overview

Brief Summary

In the study the value of capnography for avoiding complications during sedation for colonoscopy is evaluated.

Detailed Description

In this randomized controlled trial the utility of capnography gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Scheduled for colonoscopy with midazolam and propofol sedation

Exclusion Criteria

  • No informed consent
  • ASA IV or V
  • Pregnancy
  • Prexisting hypotension, bradycardia or hypoxemia

Outcomes

Primary Outcomes

Hypoxemia

Time Frame: From the start to the end of colonoscopy, i.e. from 0 h to approximately 2 h

Secondary Outcomes

  • Further complications(From the start to the end of colonoscopy, i.e. from 0 h to approximately 2 h)

Investigators

Sponsor
Technical University of Munich
Sponsor Class
Other

Study Sites (6)

Loading locations...

Similar Trials

Capnography During Colonoscopy | Clinical Trial